has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on ...
Specifically, Dupixent is approved to treat moderate to severe asthma that is either: dependent on treatment with an oral corticosteroid, or eosinophilic (caused by an increase in eosinophils ...
Systemic corticosteroids (CS) should be considered as first-line treatment for acute asthma exacerbations, especially severe exacerbations. They may sometimes require a few hours or more to ...